SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Trident Lifeline informs about outcome of board meeting

14 Nov 2022 Evaluate
Trident Lifeline has informed that the Board of Directors of the Company at its meeting held today i.e November 14, 2022 commenced at 11.00 am and concluded at 12.10 pm at the registered office of the Company has considered and approved the following; Un-Audited Financial Results (Standalone) of the Company for the half year ended on September 30, 2022 along with Limited Review Report on said results by the Statutory Auditors of the Company. Copy of Unaudited Financial Results includes Limited Review Reports as well as Cash Flow Statement, which are attached.

The above information is a part of company’s filings submitted to BSE.

Trident Lifeline Share Price

252.55 11.45 (4.75%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×